sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Biotechnology / Cell and Gene Therapy Consumables

Cell and Gene Therapy Consumables Market By Product Type (Kits & Buffers, Diagnostic Assay, Culture Medium, and Cryopreservation Media) and By Application/ Therapeutics (Cardiovascular, Urology, Dermatology, Critical Care, Respiratory, Endocrine & Metabolic, Neuroscience, Hematology & Oncology, Obstetrics, Immunology, and Gastroenterology): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027

  • Publish On: Nov-2019
  • Total Pages: 190
  • Report Code: FAF-107
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the Cell and Gene Therapy Consumables market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the Cell and Gene Therapy Consumables market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Cell and Gene Therapy Consumables market on a global level.

In order to give the users of this report a comprehensive view of the Cell and Gene Therapy Consumables market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service & product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Cell and Gene Therapy Consumables market by segmenting the market based on product type, application/therapeutics, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

A rise in the awareness about the gene & cell therapies will propel the market growth during the period from 2019 to 2027. Nevertheless, conducting randomized control tests will inhibit the expansion of the market during the forecast timeline. However, the growing trend for treating neurodegenerative ailments through the use of gene treatment will proliferate the market growth over the forecast period.

The expansion of the market during the forecast timespan is owing to the high frequency of chronic ailments including cancer and heart disorders. Apart from this, inflation in the occurrence of these disorders produces lucrative demand for enhanced therapies and this will culminate in the market demand over the forecast timespan.

Based on the product type, the market is sectored into Kits & Buffers, Diagnostic Assay, Culture Medium, and Cryopreservation Media. Application/ Therapeutics- wise, the market for cell and gene therapy consumables are classified into Cardiovascular, Urology, Dermatology, Critical Care, Respiratory, Endocrine & Metabolic, Neuroscience, Hematology & Oncology, Obstetrics, Immunology, and Gastroenterology.

Global Cell and Gene Therapy Consumables : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Cell and Gene Therapy Consumables Report:

  • Cell and Gene Therapy Consumables structure: Overview, industry life cycle analysis, supply chain analysis
  • Cell and Gene Therapy Consumables : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Cell and Gene Therapy Consumables size, trend, and forecast analysis
  • Cell and Gene Therapy Consumables segments’ trend and forecast
  • Cell and Gene Therapy Consumables ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Cell and Gene Therapy Consumables attractiveness and associated growth opportunities
  • Emerging trends in the Cell and Gene Therapy Consumables .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  1. CHAPTER 1. Executive Summary 24
  2. CHAPTER 2. Cell and Gene Therapy Consumables market – Product Type Analysis 27
    1. 2.1. Global Cell and Gene Therapy Consumables Market – Product Type Overview 27
    2. 2.2. Global Cell and Gene Therapy Consumables Market Share, by Product Type, 2018 & 2025 (USD Million) 27
    3. 2.3. Kits & Buffers 29
      1. 2.3.1. Global Kits & Buffers Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 29
    4. 2.4. Diagnostic Assay 30
      1. 2.4.1. Global Diagnostic Assay Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 30
    5. 2.5. Culture Medium 31
      1. 2.5.1. Global Culture Medium Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 31
    6. 2.6. Cryopreservation Media 32
      1. 2.6.1. Global Cryopreservation Media Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 32
  3. CHAPTER 3. Cell and Gene Therapy Consumables market – Application Analysis 32
    1. 3.1. Global Cell and Gene Therapy Consumables Market – Application Overview 32
    2. 3.2. Global Cell and Gene Therapy Consumables Market Share, by Application, 2018 & 2025 (USD Million) 33
    3. 3.3. Cardiovascular 35
      1. 3.3.1. Global Cardiovascular Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 35
    4. 3.4. Urology 36
      1. 3.4.1. Global Urology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 36
    5. 3.5. Dermatology 37
      1. 3.5.1. Global Dermatology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 37
    6. 3.6. Critical Care 38
      1. 3.6.1. Global Critical Care Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 38
    7. 3.7. Respiratory 39
      1. 3.7.1. Global Respiratory Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 39
    8. 3.8. Endocrine & Metabolic 40
      1. 3.8.1. Global Endocrine & Metabolic Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 40
    9. 3.9. Neuroscience 41
      1. 3.9.1. Global Neuroscience Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 41
    10. 3.10. Hematology & Oncology 42
      1. 3.10.1. Global Hematology & Oncology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 42
    11. 3.11. Obstetrics 43
      1. 3.11.1. Global Obstetrics Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 43
    12. 3.12. Immunology 44
      1. 3.12.1. Global Immunology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 44
    13. 3.13. Gastroenterology 45
      1. 3.13.1. Global Gastroenterology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 45
  4. CHAPTER 4. Cell and Gene Therapy Consumables market – Regional Analysis 46
    1. 4.1. Global Cell and Gene Therapy Consumables Market Regional Overview 46
    2. 4.2. Global Cell and Gene Therapy Consumables Market Share, by Region, 2018 & 2025 (Value) 46
    3. 4.3. North America 48
      1. 4.3.1. North America Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 48
      2. 4.3.2. North America Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 48
      3. 4.3.3. North America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 50
        1. 4.3.3.1. North America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 50
      4. 4.3.4. North America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 51
        1. 4.3.4.1. North America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 51
      5. 4.3.5. U.S. 52
        1. 4.3.5.1. U.S. Market size and forecast, 2015-2027 (USD Million) 52
      6. 4.3.6. Canada 53
        1. 4.3.6.1. Canada Market size and forecast, 2015-2027 (USD Million) 53
      7. 4.3.7. Mexico 54
        1. 4.3.7.1. Mexico Market size and forecast, 2015-2027 (USD Million) 54
    4. 4.4. Europe 55
      1. 4.4.1. Europe Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 55
      2. 4.4.2. Europe Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 55
      3. 4.4.3. Europe Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 57
        1. 4.4.3.1. Europe Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 57
      4. 4.4.4. Europe Cell and Gene Therapy Consumables Market, by Application, 2015-2027 58
        1. 4.4.4.1. Europe Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 58
      5. 4.4.5. Germany 59
        1. 4.4.5.1. Germany Market size and forecast, 2015-2027 (USD Million) 59
      6. 4.4.6. France 60
        1. 4.4.6.1. France Market size and forecast, 2015-2027 (USD Million) 60
      7. 4.4.7. U.K. 61
        1. 4.4.7.1. U.K. Market size and forecast, 2015-2027 (USD Million) 61
      8. 4.4.8. Italy 62
        1. 4.4.8.1. Italy Market size and forecast, 2015-2027 (USD Million) 62
      9. 4.4.9. Spain 63
        1. 4.4.9.1. Spain Market size and forecast, 2015-2027 (USD Million) 63
      10. 4.4.10. Nordic Countries 64
        1. 4.4.10.1. Nordic Countries Market size and forecast, 2015-2027 (USD Million) 64
      11. 4.4.11. Benelux Union 65
        1. 4.4.11.1. Benelux Union Market size and forecast, 2015-2027 (USD Million) 65
      12. 4.4.12. Rest of Europe 66
        1. 4.4.12.1. Rest of Europe Market size and forecast, 2015-2027 (USD Million) 66
    5. 4.5. Asia Pacific 67
      1. 4.5.1. Asia Pacific Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 67
      2. 4.5.2. Asia Pacific Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 67
      3. 4.5.3. Asia Pacific Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 69
        1. 4.5.3.1. Asia Pacific Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 69
      4. 4.5.4. Asia Pacific Cell and Gene Therapy Consumables Market, by Application, 2015-2027 70
        1. 4.5.4.1. Asia Pacific Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 70
      5. 4.5.5. China 71
        1. 4.5.5.1. China Market size and forecast, 2015-2027 (USD Million) 71
      6. 4.5.6. Japan 72
        1. 4.5.6.1. Japan Market size and forecast, 2015-2027 (USD Million) 72
      7. 4.5.7. India 73
        1. 4.5.7.1. India Market size and forecast, 2015-2027 (USD Million) 73
      8. 4.5.8. New Zealand 74
        1. 4.5.8.1. New Zealand Market size and forecast, 2015-2027 (USD Million) 74
      9. 4.5.9. Australia 75
        1. 4.5.9.1. Australia Market size and forecast, 2015-2027 (USD Million) 75
      10. 4.5.10. South Korea 76
        1. 4.5.10.1. South Korea Market size and forecast, 2015-2027 (USD Million) 76
      11. 4.5.11. South-East Asia 77
        1. 4.5.11.1. South-East Asia Market size and forecast, 2015-2027 (USD Million) 77
      12. 4.5.12. Rest of Asia Pacific 78
        1. 4.5.12.1. Rest of Asia Pacific Market size and forecast, 2015-2027 (USD Million) 78
    6. 4.6. Latin America 79
      1. 4.6.1. Latin America Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 79
      2. 4.6.2. Latin America Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 79
      3. 4.6.3. Latin America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 81
        1. 4.6.3.1. Latin America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 81
      4. 4.6.4. Latin America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 82
        1. 4.6.4.1. Latin America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 82
      5. 4.6.5. Brazil 83
        1. 4.6.5.1. Brazil Market size and forecast, 2015-2027 (USD Million) 83
      6. 4.6.6. Argentina 84
        1. 4.6.6.1. Argentina Market size and forecast, 2015-2027 (USD Million) 84
      7. 4.6.7. Rest of Latin America 85
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2015-2027 (USD Million) 85
    7. 4.7. The Middle-East and Africa 86
      1. 4.7.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market size and forecast, 2015-2027 86
      2. 4.7.2. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Country, 2018 & 2025 (USD Million) 86
      3. 4.7.3. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 88
        1. 4.7.3.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 88
      4. 4.7.4. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Application, 2015-2027 89
        1. 4.7.4.1. The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 89
      5. 4.7.5. Saudi Arabia 90
        1. 4.7.5.1. Saudi Arabia Market size and forecast, 2015-2027 (USD Million) 90
      6. 4.7.6. UAE 91
        1. 4.7.6.1. UAE Market size and forecast, 2015-2027 (USD Million) 91
      7. 4.7.7. Egypt 92
        1. 4.7.7.1. Egypt Market size and forecast, 2015-2027 (USD Million) 92
      8. 4.7.8. Kuwait 93
        1. 4.7.8.1. Kuwait Market size and forecast, 2015-2027 (USD Million) 93
      9. 4.7.9. South Africa 94
        1. 4.7.9.1. South Africa Market size and forecast, 2015-2027 (USD Million) 94
      10. 4.7.10. Rest of Middle-East Africa 95
        1. 4.7.10.1. Rest of Middle-East Africa Market size and forecast, 2015-2027 (USD Million) 95
  5. CHAPTER 5. Cell and Gene Therapy Consumables market – Competitive Landscape 96
    1. 5.1. Competitor Market Share – Revenue 96
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 98
    3. 5.3. Strategic Development 99
      1. 5.3.1. Acquisitions and Mergers 99
      2. 5.3.2. New Products 99
      3. 5.3.3. Research & Development Activities 99
  6. CHAPTER 6. Company Profiles 100
    1. 6.1. Amgen Inc. 100
      1. 6.1.1. Company Overview 100
      2. 6.1.2. Amgen Inc. Revenue and Gross Margin 100
      3. 6.1.3. Product portfolio 101
      4. 6.1.4. Recent initiatives 102
    2. 6.2. ATLANTA BIOLOGICALS 102
      1. 6.2.1. Company Overview 102
      2. 6.2.2. ATLANTA BIOLOGICALS Revenue and Gross Margin 102
      3. 6.2.3. Product portfolio 103
      4. 6.2.4. Recent initiatives 104
    3. 6.3. bluebird bio Inc. 104
      1. 6.3.1. Company Overview 104
      2. 6.3.2. bluebird bio Inc. Revenue and Gross Margin 104
      3. 6.3.3. Product portfolio 105
      4. 6.3.4. Recent initiatives 106
    4. 6.4. Cook 106
      1. 6.4.1. Company Overview 106
      2. 6.4.2. Cook Revenue and Gross Margin 106
      3. 6.4.3. Product portfolio 107
      4. 6.4.4. Recent initiatives 108
    5. 6.5. Dendreon Pharmaceuticals LLC 108
      1. 6.5.1. Company Overview 108
      2. 6.5.2. Dendreon Pharmaceuticals LLC Revenue and Gross Margin 108
      3. 6.5.3. Product portfolio 109
      4. 6.5.4. Recent initiatives 110
    6. 6.6. Fibrocell Science Inc. 110
      1. 6.6.1. Company Overview 110
      2. 6.6.2. Fibrocell Science Inc. Revenue and Gross Margin 110
      3. 6.6.3. Product portfolio 111
      4. 6.6.4. Recent initiatives 112
    7. 6.7. General Electric 112
      1. 6.7.1. Company Overview 112
      2. 6.7.2. General Electric Revenue and Gross Margin 112
      3. 6.7.3. Product portfolio 113
      4. 6.7.4. Recent initiatives 114
    8. 6.8. Kolon TissueGene Inc. 114
      1. 6.8.1. Company Overview 114
      2. 6.8.2. Kolon TissueGene Inc. Revenue and Gross Margin 114
      3. 6.8.3. Product portfolio 115
      4. 6.8.4. Recent initiatives 116
    9. 6.9. Orchard Therapeutics plc. 116
      1. 6.9.1. Company Overview 116
      2. 6.9.2. Orchard Therapeutics plc. Revenue and Gross Margin 116
      3. 6.9.3. Product portfolio 117
      4. 6.9.4. Recent initiatives 118
    10. 6.10. Pfizer Inc. 118
      1. 6.10.1. Company Overview 118
      2. 6.10.2. Pfizer Inc. Revenue and Gross Margin 118
      3. 6.10.3. Product portfolio 119
      4. 6.10.4. Recent initiatives 120
    11. 6.11. PromoCell GmbH 120
      1. 6.11.1. Company Overview 120
      2. 6.11.2. PromoCell GmbH Revenue and Gross Margin 120
      3. 6.11.3. Product portfolio 121
      4. 6.11.4. Recent initiatives 122
    12. 6.12. RENOVA THERAPEUTICS 122
      1. 6.12.1. Company Overview 122
      2. 6.12.2. RENOVA THERAPEUTICS Revenue and Gross Margin 122
      3. 6.12.3. Product portfolio 123
      4. 6.12.4. Recent initiatives 124
    13. 6.13. Sibiono GeneTech Co. Ltd. 124
      1. 6.13.1. Company Overview 124
      2. 6.13.2. Sibiono GeneTech Co. Ltd. Revenue and Gross Margin 124
      3. 6.13.3. Product portfolio 125
      4. 6.13.4. Recent initiatives 126
    14. 6.14. Spark Therapeutics Inc. 126
      1. 6.14.1. Company Overview 126
      2. 6.14.2. Spark Therapeutics Inc. Revenue and Gross Margin 126
      3. 6.14.3. Product portfolio 127
      4. 6.14.4. Recent initiatives 128
    15. 6.15. Vericel 128
      1. 6.15.1. Company Overview 128
      2. 6.15.2. Vericel Revenue and Gross Margin 128
      3. 6.15.3. Product portfolio 129
      4. 6.15.4. Recent initiatives 130
    16. 6.16. Helixmith Co. Ltd. 130
      1. 6.16.1. Company Overview 130
      2. 6.16.2. Helixmith Co. Ltd. Revenue and Gross Margin 130
      3. 6.16.3. Product portfolio 131
      4. 6.16.4. Recent initiatives 132
    17. 6.17. Vitrolife 132
      1. 6.17.1. Company Overview 132
      2. 6.17.2. Vitrolife Revenue and Gross Margin 132
      3. 6.17.3. Product portfolio 133
      4. 6.17.4. Recent initiatives 134
  7. CHAPTER 7. Cell and Gene Therapy Consumables — Industry Analysis 135
    1. 7.1. Cell and Gene Therapy Consumables Market – Key Trends 135
      1. 7.1.1. Market Drivers 136
      2. 7.1.2. Market Restraints 136
      3. 7.1.3. Market Opportunities 137
    2. 7.2. Value Chain Analysis 138
    3. 7.3. Technology Roadmap and Timeline 139
    4. 7.4. Cell and Gene Therapy Consumables Market – Attractiveness Analysis 140
      1. 7.4.1. By Product Type 140
      2. 7.4.2. By Application 140
      3. 7.4.3. By Region 142
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors 143
    1. 8.1. Marketing Channel 143
    2. 8.2. Direct Marketing 144
    3. 8.3. Indirect Marketing 144
    4. 8.4. Marketing Channel Development Trend 144
    5. 8.5. Economic/Political Environmental Change 145
  9. CHAPTER 9. Report Conclusion 146
  10. CHAPTER 10. Research Approach & Methodology 147
    1. 10.1. Report Description 147
    2. 10.2. Research Scope 148
    3. 10.3. Research Methodology 148
      1. 10.3.1. Secondary Research 149
      2. 10.3.2. Primary Research 150
      3. 10.3.3. Models 151
        1. 10.3.3.1. Company Share Analysis Model 151
        2. 10.3.3.2. Revenue Based Modeling 152
        3. 10.3.3.3. Research Limitations 152

        List of Figures

        FIG. 1 Global Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 26
        FIG. 2 Global Cell and Gene Therapy Consumables Market Share, by Product Type, 2018 & 2025 (USD Million) 27
        FIG. 3 Global Kits & Buffers Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 29
        FIG. 4 Global Diagnostic Assay Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 30
        FIG. 5 Global Culture Medium Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 31
        FIG. 6 Global Cryopreservation Media Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 32
        FIG. 7 Global Cell and Gene Therapy Consumables Market Share, by Application, 2018 & 2025 (USD Million) 33
        FIG. 8 Global Cardiovascular Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 35
        FIG. 9 Global Urology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 36
        FIG. 10 Global Dermatology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 37
        FIG. 11 Global Critical Care Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 38
        FIG. 12 Global Respiratory Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 39
        FIG. 13 Global Endocrine & Metabolic Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 40
        FIG. 14 Global Neuroscience Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 41
        FIG. 15 Global Hematology & Oncology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 42
        FIG. 16 Global Obstetrics Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 43
        FIG. 17 Global Immunology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 44
        FIG. 18 Global Gastroenterology Cell and Gene Therapy Consumables Market, 2015-2027 (USD Million) 45
        FIG. 19 Global Cell and Gene Therapy Consumables Market Share, by Region, 2018 & 2025 46
        FIG. 20 North America Cell and Gene Therapy Consumables Market, 2015-2027 48
        FIG. 21 U.S. Cell and Gene Therapy Consumables Market, 2015-2027 52
        FIG. 22 Canada Cell and Gene Therapy Consumables Market, 2015-2027 53
        FIG. 23 Mexico Cell and Gene Therapy Consumables Market, 2015-2027 54
        FIG. 24 Europe Cell and Gene Therapy Consumables Market, 2015-2027 55
        FIG. 25 Germany Cell and Gene Therapy Consumables Market, 2015-2027 59
        FIG. 26 France Cell and Gene Therapy Consumables Market, 2015-2027 60
        FIG. 27 U.K. Cell and Gene Therapy Consumables Market, 2015-2027 61
        FIG. 28 Italy Cell and Gene Therapy Consumables Market, 2015-2027 62
        FIG. 29 Spain Cell and Gene Therapy Consumables Market, 2015-2027 63
        FIG. 30 Nordic Countries Cell and Gene Therapy Consumables Market, 2015-2027 64
        FIG. 31 Benelux Union Cell and Gene Therapy Consumables Market, 2015-2027 65
        FIG. 32 Rest of Europe Cell and Gene Therapy Consumables Market, 2015-2027 66
        FIG. 33 Asia Pacific Cell and Gene Therapy Consumables Market, 2015-2027 67
        FIG. 34 China Cell and Gene Therapy Consumables Market, 2015-2027 71
        FIG. 35 Japan Cell and Gene Therapy Consumables Market, 2015-2027 72
        FIG. 36 India Cell and Gene Therapy Consumables Market, 2015-2027 73
        FIG. 37 New Zealand Cell and Gene Therapy Consumables Market, 2015-2027 74
        FIG. 38 Australia Cell and Gene Therapy Consumables Market, 2015-2027 75
        FIG. 39 South  Korea Cell and Gene Therapy Consumables Market, 2015-2027 76
        FIG. 40 South-East Asia Cell and Gene Therapy Consumables Market, 2015-2027 77
        FIG. 41 Rest of Asia Pacific Cell and Gene Therapy Consumables Market, 2015-2027 78
        FIG. 42 Latin America Cell and Gene Therapy Consumables Market, 2015-2027 79
        FIG. 43 Brazil Cell and Gene Therapy Consumables Market, 2015-2027 83
        FIG. 44 Argentina Cell and Gene Therapy Consumables Market, 2015-2027 84
        FIG. 45 Rest of Latin America Cell and Gene Therapy Consumables Market, 2015-2027 85
        FIG. 46 The Middle-East and Africa Cell and Gene Therapy Consumables Market, 2015-2027 86
        FIG. 47 Saudi Arabia Cell and Gene Therapy Consumables Market, 2015-2027 90
        FIG. 48 UAE Cell and Gene Therapy Consumables Market, 2015-2027 91
        FIG. 49 Egypt Cell and Gene Therapy Consumables Market, 2015-2027 92
        FIG. 50 Kuwait Cell and Gene Therapy Consumables Market, 2015-2027 93
        FIG. 51 South Africa Cell and Gene Therapy Consumables Market, 2015-2027 94
        FIG. 52 Rest of Middle-East Africa Cell and Gene Therapy Consumables Market, 2015-2027 95
        FIG. 53 Competitor Market Share – Revenue 96
        FIG. 54 Amgen Inc. Revenue and Growth Rate 101
        FIG. 55 Amgen Inc. Market Share 101
        FIG. 56 ATLANTA BIOLOGICALS Revenue and Growth Rate 103
        FIG. 57 ATLANTA BIOLOGICALS Market Share 103
        FIG. 58 bluebird bio Inc. Revenue and Growth Rate 105
        FIG. 59 bluebird bio Inc. Market Share 105
        FIG. 60 Cook Revenue and Growth Rate 107
        FIG. 61 Cook Market Share 107
        FIG. 62 Dendreon Pharmaceuticals LLC Revenue and Growth Rate 109
        FIG. 63 Dendreon Pharmaceuticals LLC Market Share 109
        FIG. 64 Fibrocell Science Inc. Revenue and Growth Rate 111
        FIG. 65 Fibrocell Science Inc. Market Share 111
        FIG. 66 General Electric Revenue and Growth Rate 113
        FIG. 67 General Electric Market Share 113
        FIG. 68 Kolon TissueGene Inc. Revenue and Growth Rate 115
        FIG. 69 Kolon TissueGene Inc. Market Share 115
        FIG. 70 Orchard Therapeutics plc. Revenue and Growth Rate 117
        FIG. 71 Orchard Therapeutics plc. Market Share 117
        FIG. 72 Pfizer Inc. Revenue and Growth Rate 119
        FIG. 73 Pfizer Inc. Market Share 119
        FIG. 74 PromoCell GmbH Revenue and Growth Rate 121
        FIG. 75 PromoCell GmbH Market Share 121
        FIG. 76 RENOVA THERAPEUTICS Revenue and Growth Rate 123
        FIG. 77 RENOVA THERAPEUTICS Market Share 123
        FIG. 78 Sibiono GeneTech Co. Ltd. Revenue and Growth Rate 125
        FIG. 79 Sibiono GeneTech Co. Ltd. Market Share 125
        FIG. 80 Spark Therapeutics Inc. Revenue and Growth Rate 127
        FIG. 81 Spark Therapeutics Inc. Market Share 127
        FIG. 82 Vericel Revenue and Growth Rate 129
        FIG. 83 Vericel Market Share 129
        FIG. 84 Helixmith Co. Ltd. Revenue and Growth Rate 131
        FIG. 85 Helixmith Co. Ltd. Market Share 131
        FIG. 86 Vitrolife Revenue and Growth Rate 133
        FIG. 87 Vitrolife Market Share 133
        FIG. 88 Market Dynamics 135
        FIG. 89 Global Cell and Gene Therapy Consumables – Value Chain Analysis 138
        FIG. 90 Technology Roadmap and Timeline 139
        FIG. 91 Market Attractiveness Analysis – By Product Type 140
        FIG. 92 Market Attractiveness Analysis – By Application 141
        FIG. 93 Market Attractiveness Analysis – By Region 142
        FIG. 94 Market Channel 143
        FIG. 95 Marketing Channel Development Trend 144
        FIG. 96 Growth in World Gross Product, 2008-2018 145
        
        

        List of Tables

        TABLE 1 Global Cell and Gene Therapy Consumables Market, 2018 & 2025 (USD Million) 24
        TABLE 2 Global Cell and Gene Therapy Consumables market, by Product Type, 2015-2027 (USD Million) 27
        TABLE 3 Global Cell and Gene Therapy Consumables market, by Application, 2015-2027 (USD Million) 33
        TABLE 4 Global Cell and Gene Therapy Consumables market, by Region, 2015-2027 (USD Million) 46
        TABLE 5 North America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 50
        TABLE 6 North America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 51
        TABLE 7 Europe Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 57
        TABLE 8 Europe Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 58
        TABLE 9 Asia Pacific Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 69
        TABLE 10 Asia Pacific Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 70
        TABLE 11 Latin America Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 81
        TABLE 12 Latin America Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 82
        TABLE 13 The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Product Type, 2015-2027 (USD Million) 88
        TABLE 14 The Middle-East and Africa Cell and Gene Therapy Consumables Market, by Application, 2015-2027 (USD Million) 89
        TABLE 15 Global Cell and Gene Therapy Consumables Market - Company Revenue Analysis 2015-2018 (USD Million) 96
        TABLE 16 Global Cell and Gene Therapy Consumables Market - Company Revenue Share Analysis 2015-2018 (%) 98
        TABLE 17 Acquisitions and Mergers 99
        TABLE 18 New Product/Service Launch 99
        TABLE 19 Research & Development Activities 99
        TABLE 20 Market Drivers 136
        TABLE 21 Market Restraints 136
        TABLE 22 Market Opportunities 137
        

Industry Major Market Players

  •  Amgen Inc.,
  •  ATLANTA BIOLOGICALS,
  •  bluebird bio Inc.,
  •  Cook,
  •  Dendreon Pharmaceuticals,
  •  LLC,
  •  Fibrocell Science Inc.,
  •  General Electric,
  •  Kolon TissueGene Inc.,
  •  Orchard Therapeutics plc.,
  •  Pfizer Inc.,
  •  PromoCell GmbH,
  •  RENOVA THERAPEUTICS,
  •  Sibiono GeneTech Co. Ltd.,
  •  Spark Therapeutics Inc.,
  •  Vericel,
  •  Helixmith Co.,
  •  Ltd.,
  •  Vitrolife.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions